MedPath
NMPA Approval

Febuxostat Tablets

国药准字H20243520

April 17, 2024

Drug Information

非布司他片

片剂

40mg

化学药品

April 17, 2024

Company Information

Applicant Company

海口市金盘开发区美国工业村2-4号

Manufacturing Company

海口市金盘开发区美国工业村2-4号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

非布司他片 - NMPA 批准文号 | MedPath